* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
David Caplan
Vice President and General Counsel
New York, New York
11/14/2023
Per the guidance provided in Special Instruction 4: This Form 13F Combination Report for Atairos Partners GP, Inc. is being filed to correct a prior filing with a typographical error. Previously, a Form 13F Combination Report for Atairos Partners GP, Inc. (Accession No. 0000950103-23-013333) was filed with a 03/31/2022 reporting period. The reporting period should have been listed as 03/31/2023, and all information referenced in such prior filing should be read to apply to a 03/31/2023 reporting period as identified in this Form 13F Combination Report.
List of Other Managers Reporting for Atairos Partners GP, Inc.:
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.